PTPI - Petros Pharmaceuticals, Inc.

0.1478
-0.049   -33.288%

Share volume: 8,269,565
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%
$0.20
-0.05
-0.25%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-15-2024 08-14-2023 11-15-2023 11-13-2024 05-15-2024 08-14-2024 11-13-2024
Total revenue 2.518 M 1.994 M 1.675 M -364.252 K 1.389 M 1.421 M 1.576 M
Cost of revenue 550.742 K 513.857 K 408.475 K 158.146 K 331.831 K 329.110 K 287.005 K
Gross profit 1.967 M 1.480 M 1.266 M -522.398 K 1.057 M 1.092 M 1.289 M
    -24.76% -14.46% -141.26% 302.33% 3.35% 18.03%  
Operating expenses 2.450 M 3.116 M 2.391 M 3.714 M 4.267 M 2.655 M 2.890 M
Selling general and admin 2.131 M 2.250 M 2.002 M 2.879 M 2.711 M 2.287 M 2.301 M
Research and development 319.093 K 866.575 K 389.093 K 834.333 K 1.556 M 368.798 K 588.355 K
Total expenses 3.277 M 3.943 M 6.073 M 4.516 M 4.985 M 3.373 M 3.629 M
    20.34% 54.02% -25.63% 10.39% -32.34% 7.58%  
Operating income -1.309 M -2.463 M -4.807 M -5.039 M -3.928 M -2.281 M -2.340 M
Ebit -1.309 M -2.463 M -4.587 M 216.382 K -2.194 M -666.905 K -2.138 M
Pretax income -1.385 M -2.547 M -4.550 M 318.150 K -2.163 M -662.026 K -2.221 M
    83.86% 78.64% -106.99% -779.76% -69.39% 235.43%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -1.385 M -2.547 M -4.550 M 318.150 K -2.163 M -662.026 K -2.221 M
    -83.86% -78.64% 106.99% -779.76% 69.39% -235.43%